(Q27852242)

English

Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network

scientific article

  • Adverse Outcomes in Clear Cell Renal Cell Carcinoma with Mutations of 3p21 Epigenetic Regulators BAP1 and SETD2: A Report by MSKCC and the KIRC TCGA Research Network

Statements

Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network (English)
1 reference
0 references
0 references
0 references
0 references
0 references
0 references
A Ari Hakimi
0 references
Irina Ostrovnaya
0 references
Mithat Gonen
0 references
Han Liu
0 references
Martin H Voss
0 references
Satish K Tickoo
0 references
Victor E Reuter
0 references
Paul Russo
0 references
Emily H Cheng
0 references
James J Hsieh
0 references
15 June 2013
0 references
19
0 references
3259-67
0 references
12
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit